Although the link between obesity and risk of prostate cancer is not well established, studies suggested associations between obesity and prostate cancer-specific mortality and biochemical recurrence detected via prostate-specific antigen test (16–19). The gene discussed is KLK3; the disease is obesity due to melanocortin 4 receptor deficiency.